The quantitative luminescent kinase assay ADP-Glo™ was used to screen CK2 inhibitors from the natural product library.
To identity novel classes of inhibitors for CK2, we screened a natural product library obtained from National Cancer Institute. CK2 overexpression is associated with multiple human cancers and may therefore be a promising target for cancer therapy. Casein kinase 2 (CK2) is involved in various cellular events such as proliferation, apoptosis, and the cell cycle.
0 kommentar(er)
